Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01689909 · ClinicalTrials.gov registry record · Phase 4
Reducing Suicidal Ideation Through Insomnia Treatment
A Phase 4 study, sponsored by Augusta University.
- Completed
- Registry status
- Phase 4
- Development phase
- 103
- Enrollment target
NCT01689909 is a Phase 4 study that has completed, run by Augusta University. The registered enrollment target is 103 participants.
The verdict
NCT01689909, a Phase 4 study, has completed, sponsored by Augusta University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 103 participants
- Enrollment target
Study Summary
Epidemiologic reports have linked insomnia to suicidal ideation and suicide death. However, no studies have determined whether treating insomnia decreases the risk of suicidality. We have new data indicating that (1) the link between insomnia and suicidal ideation holds true in clinical trials of depressed insomniacs, (2) dysfunctional cognitions about sleep are related to suicidal ideas, and (3) treatment of insomnia with hypnotics leads to a reduction of suicidal ideation. We now propose to test whether cautious use of hypnotics in suicidal, depressed insomniacs may reduce suicide risk in a multi-site clinical trial.
Interventions
- DRUG Placebo
- DRUG Zolpidem-CR
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 103 participants |
| Start Date | 2012-12-06 |
| Est. Completion | 2018-01-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01689909
The ClinicalTrials.gov registry entry for NCT01689909 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 103 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Augusta University, which has 106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01689909 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01689909 about?
NCT01689909 is a clinical study titled "Reducing Suicidal Ideation Through Insomnia Treatment". Epidemiologic reports have linked insomnia to suicidal ideation and suicide death. However, no studies have determined whether treating insomnia decreases the risk of suicidality. We have new data indicating that (1) the link between insomnia and suicidal ideation holds true in clinical trials of de...
What is the current status of trial NCT01689909?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 103 participants. The study started on 2012-12-06. Estimated completion is 2018-01-01.
What interventions are being tested in trial NCT01689909?
The interventions under investigation include: Placebo (DRUG), Zolpidem-CR (DRUG).
Who is sponsoring clinical trial NCT01689909?
This trial is sponsored by Augusta University, which has 106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.